Zdrowie i gospodarka · 28/10/2020

FDA Releases Final Guidance on Referencing Approved Drug Products in Abbreviated New Drug Application Submissions

The Food and Drug Administration (FDA) has made available a final guidance document that outlines the process for referencing approved drug products in abbreviated new drug application (ANDA) submissions, allowing generic drug manufacturers to seek FDA approval for their versions of previously approved medications.